Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-33.37	59.65	89.53
Graham Fair Price	17.72	10782.94	9159.96
PEG	-16.88	-0.03	0.04
Price/Book	5.41	0.43	0.40
Price/Cash Flow	-41.15	-8.05	-5.70
Prices/Earnings	-23.10	7.20	-9.37
Price/Sales	-13.02	2.37	2.73
Price/FCF	-41.15	-8.05	-5.70
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	1.75	0.85	0.84
Operating Margin	34.89	0.69	0.51
ROA	29.23	< 0.005	< 0.005
ROE	-0.01	0.01	37.08
ROIC	< 0.005	0.01	53.32
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.08	1.32	-93.66
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	12.00	0.64	-94.65
EPS QOQ	-2.57	2.38	-7.49
FCF QOQ	-17.88	0.25	-98.60
Revenue QOQ	1.90	0.22	-88.56
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	2769.81	2557.59	-7.66
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.87	0.88	0.96
Quick Ratio	1.14	1.19	4.13
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	18583.46	18684.50	0.54
Cash	3535.88	3410.83	-3.54
Capex	-20.81	-6.83	67.15
Free Cash Flow	-1318.75	-990.19	24.91
Revenue	2755.66	3357.75	21.85
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.00	0.00	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	84.35	56.28	-33.28
Naive Interpretation	Member

06 - Financial Health · Bad

Rating